These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 18774492)

  • 1. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
    Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
    Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas.
    Majumdar K; Radotra BD; Vasishta RK; Pathak A
    Surg Neurol; 2009 Jul; 72(1):54-60. PubMed ID: 19559929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MBP and GFAP immunohistochemistry of oligodendrogliomas with relationship to myelin-forming glia in cell differentiation].
    Hokama Y; Tanaka J; Nakamura H; Hori T
    No To Shinkei; 1986 Apr; 38(4):379-86. PubMed ID: 2424482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathological study of oligodendroglioma with special reference to immunohistochemical investigation].
    Kubo O; Tajika Y; Toyama T; Tajika T; Sakairi M; Katahira M; Kitamura K
    No Shinkei Geka; 1988 Aug; 16(9):1029-35. PubMed ID: 2462693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and survival-related factors in patients with well-differentiated oligodendrogliomas.
    Maiuri F; Del Basso De Caro ML; Iaconetta G; Peca C; Esposito M; de Divitiis E
    Zentralbl Neurochir; 2006 Nov; 67(4):204-9. PubMed ID: 17106834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
    Prayson RA; Mohan DS; Song P; Suh JH
    Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival.
    Korkolopoulou P; Levidou G; Saetta AA; El-Habr E; Eftichiadis C; Demenagas P; Thymara I; Xiromeritis K; Boviatsis E; Thomas-Tsagli E; Panayotidis I; Patsouris E
    Hum Pathol; 2008 Aug; 39(8):1143-52. PubMed ID: 18495209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cell proliferation and glial fibrillary acidic protein in brain tumors].
    Kunz J; Gottschalk J; Jänisch W; Schulz W
    Acta Histochem; 1986; 80(1):53-61. PubMed ID: 3099535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
    Reyaz N; Tayyab M; Khan SA; Siddique T
    J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation and cell death in oligodendrogliomas.
    Wharton SB; Hamilton FA; Chan WK; Chan KK; Anderson JR
    Neuropathol Appl Neurobiol; 1998 Feb; 24(1):21-8. PubMed ID: 9549725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GFAP-positive neoplastic astrocytes in spontaneous oligodendrogliomas and mixed gliomas of rats.
    Nagatani M; Yamakawa S; Saito T; Ando R; Hoshiya T; Tamura K; Uchida K
    Toxicol Pathol; 2013; 41(4):653-61. PubMed ID: 23076037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
    Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
    Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 in oligodendroglial neoplasms.
    Castilla EA; Prayson RA; Kanner AA; Rybicki LA; Tubbs RR; Vogelbaum MA; Barnett GH
    Cancer; 2003 Oct; 98(7):1465-72. PubMed ID: 14508834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvessel density in brain tumors.
    Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
    Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 labeling correlates positively in tumor cells and negatively in endothelial cells with malignancy and poor prognosis in oligodendroglioma patients.
    Deininger MH; Trautmann K; Meyermann R; Schluesener HJ
    Anticancer Res; 2002; 22(3):1585-92. PubMed ID: 12168841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.
    Cassoni P; Senetta R; Castellano I; Ortolan E; Bosco M; Magnani I; Ducati A
    Am J Surg Pathol; 2007 May; 31(5):760-9. PubMed ID: 17460461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of malignant features in oligodendroglial tumors.
    Saito A; Nakazato Y
    Clin Neuropathol; 1999; 18(2):61-73. PubMed ID: 10192700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
    Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
    Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced glial fibrillary acidic protein-delta expression in human astrocytic tumor.
    Choi KC; Kwak SE; Kim JE; Sheen SH; Kang TC
    Neurosci Lett; 2009 Oct; 463(3):182-7. PubMed ID: 19647039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status.
    Barresi V; Buttarelli FR; Vitarelli EE; Arcella A; Antonelli M; Giangaspero F
    Hum Pathol; 2009 Dec; 40(12):1738-46. PubMed ID: 19716156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.